Capillary tubes are tiny tubes with a narrow diameter used in various applications such as medical and dental instruments, chromatography, and sensitive pressure measurement. Mardia Samyoung Capillary Tubes Co. is a significant player in this market and provides high-quality capillary tubes to various industries across the globe. In this article, we will take a closer look at Mardia Samyoung Capillary Tubes Co. and its competitors, and compare them in terms of market cap, sales, net profit and assets.
Mardia Samyoung Capillary Tubes Co.: An Overview
Mardia Samyoung Capillary Tubes Co. is a South Korean-based company founded in 1995 that specializes in manufacturing capillary tubes with a diameter ranging from 0.1mm to 5mm. These tubes are used in various industries such as medical, semiconductor, petrochemical, and automotive, to name a few. Mardia Samyoung Capillary Tubes Co. is equipped with state-of-the-art technology and a team of experts who ensure the quality of the products. The company claims to have an annual production capacity of 800 tons, which gives them a significant advantage in the market.
ANTON: A Competitor in the Market
ANTON is a Chinese-based company that deals with metal material products. The company claims to have over 30,000 tons of perennial stock, which they process and turn into various metal products such as tube, pipe, bar, extrusions, strip, foil, sheet, and coil made from stainless steel, nickel alloy, and titanium. The company has a reputation for providing high-quality products and is known for its excellent customer service. Mardia Samyoung Capillary Tubes Co. may face a tough competition from ANTON in the future as the latter expands its product line into the capillary tubes market.
Market Cap
As of 2021, Mardia Samyoung Capillary Tubes Co. has a market cap of approximately 26 million USD. This market cap is relatively small compared to some of its competitors. For instance, ANTON has a market cap of 360 million USD, which is more than ten times that of Mardia Samyoung Capillary Tubes Co.
Sales
In terms of sales, Mardia Samyoung Capillary Tubes Co. has been experiencing steady growth over the years. In 2019, the company reported sales revenue of 19 million USD, which increased to 21 million USD in 2020. ANTON, on the other hand, reported sales of 550 million USD in 2019 and 600 million USD in 2020. This shows that ANTON has a significantly higher sales volume than Mardia Samyoung Capillary Tubes Co.
Net Profit
Net profit is the amount of money a company makes after deducting all expenses, including taxes, from its revenue. In 2019, Mardia Samyoung Capillary Tubes Co. reported a net profit of 1 million USD, which increased to 2 million USD in 2020. ANTON, on the other hand, reported a net profit of 33 million USD in 2019 and 40 million USD in 2020. This shows that ANTON has a higher net profit margin than Mardia Samyoung Capillary Tubes Co.
Assets
In terms of assets, Mardia Samyoung Capillary Tubes Co. has approximately 21 million USD, whereas ANTON has around 400 million USD. ANTON's total assets are significantly higher than that of Mardia Samyoung Capillary Tubes Co., which may give them a competitive advantage in the future.
In conclusion, Mardia Samyoung Capillary Tubes Co. is a promising player in the capillary tubes market. The company has been growing steadily over the years and providing high-quality products to various industries. However, the company faces tough competition from its Chinese counterpart ANTON, which has a more substantial market cap, higher sales volume, net profit margin, and assets. Mardia Samyoung Capillary Tubes Co. needs to find ways to compete with ANTON and establish its position as a major player in the market.